Apple Eyes U.S. Formula 1 Broadcast Rights in Major Sports Streaming Push 
Oil Prices Hold Near Multi-Year Highs Amid Iran Conflict and Hormuz Supply Fears 
South Korea Manufacturing PMI Hits 4-Year High in March 2025 Driven by Semiconductor Demand 
Australia's Trade Surplus Surges in February on Gold Export Boom 
U.S. Dollar Posts Strong Monthly Gain Amid Middle East Conflict Despite Late Dip 
RBI Clamps Down on Rupee NDF Activity, Banks Face Steeper Losses 
Trump Plans UFC Event at White House for America’s 250th Anniversary 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand 
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs 
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 
NBA Returns to China with Alibaba Partnership and Historic Macau Games 
Bank of America's $72.5M Epstein Settlement: What You Need to Know 
Apple Turns 50: From Garage Startup to AI Crossroads 
Japan Business Sentiment Rises as Iran War Fuels Inflation Fears, BOJ Rate Hike Looms 
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 
The late Lakers icon Kobe Bryant's investment for a 10 percent stake in sports drink BodyArmor for just $6 million in the company way back in 2014 has grown to $800 million.
That incredible gain surpassed by two and a half times more Bryant’s career NBA earnings of roughly $323 million in his 20 seasons playing for the Los Angeles Lakers.
When Coca-Cola acquired a minority stake in the sports drink company in 2018, Bryant's shares immediately soared to around $200 million.
Coca-Cola is reportedly close to acquiring a controlling stake in sports BodyArmor for $8 billion, which could be announced as early as Monday.
The Lakers icon keeps proving that he excelled outside the court.
After Bryant retired from the NBA in 2016, his "Dear Basketball" production brought him an Oscar for the best animated short film.
